Reliability-centered maintenance

R1 RCM to Release First Quarter 2024 Results on May 8, 2024

Retrieved on: 
Monday, April 1, 2024

MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m.

Key Points: 
  • MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m.
  • ET to review the results.
  • Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144 (646-968-2525 outside the U.S. and Canada) using conference code number 9123341.
  • A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at r1rcm.com.

R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report

Retrieved on: 
Wednesday, March 27, 2024

MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report .

Key Points: 
  • MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report .
  • The report details the company’s commitment to improving access to healthcare, bringing responsible global citizenship to life through its ESG program.
  • R1 does not undertake to update its forward-looking statements except to the extent required by applicable law.
  • All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements.

R1 RCM Forms Special Committee to Evaluate Strategic Alternatives

Retrieved on: 
Monday, March 11, 2024

MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C.

Key Points: 
  • MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C.
  • Consistent with its fiduciary duties, and in consultation with its independent advisors, the Special Committee will carefully review the communications from New Mountain Capital and evaluate strategic alternatives to determine the course of action that it believes is in the best interests of R1 and its stockholders.
  • R1 remains focused on providing clients with world-class revenue cycle solutions to help providers improve their financial performance and deliver an exceptional patient experience.
  • No assurances can be given regarding the outcome or timing of the Special Committee’s review process.

R1 RCM Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Tuesday, February 27, 2024

MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023.

Key Points: 
  • MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023.
  • Our strategy is to leverage our best-in-class capabilities to deploy flexible models that meet customers where they are in their revenue cycle journey.
  • R1’s management team will host a conference call today at 8:00 a.m. Eastern Time to discuss its financial results and business outlook.
  • Subsequent events and developments, including actual results or changes in the Company’s assumptions, may cause the Company’s views to change.

R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Retrieved on: 
Friday, March 1, 2024

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).

Key Points: 
  • Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).
  • Investors who purchased R1 securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RCM .
  • You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Retrieved on: 
Wednesday, February 28, 2024

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).

Key Points: 
  • Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM).
  • Investors who purchased R1 securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RCM .
  • You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Coliseum Capital Issues Open Letter to Board of R1 RCM on Offer by New Mountain to Acquire the Company for $13.75 Per Share

Retrieved on: 
Monday, February 26, 2024

Coliseum Capital Management, LLC (“Coliseum”), one of the largest shareholders of R1 RCM Inc. (NASDAQ: RCM) (“Company”), today announced that it has issued an open letter to the Company’s Board of Directors.

Key Points: 
  • Coliseum Capital Management, LLC (“Coliseum”), one of the largest shareholders of R1 RCM Inc. (NASDAQ: RCM) (“Company”), today announced that it has issued an open letter to the Company’s Board of Directors.
  • In its letter, Coliseum states that it believes the offer by New Mountain Capital, L.L.C.
  • to acquire the Company for cash consideration of $13.75 per share significantly undervalues the Company.
  • The letter also expresses support for the Company’s Board of Directors, management team, and strategy for shareholder value creation.

Revenue cycle management (RCM) market size in US to grow by USD 11.98 billion from 2022 to 2027, Growing adoption of a value-based reimbursement model to be a major trend, Technavio

Retrieved on: 
Wednesday, March 6, 2024

athenahealth Inc. - The company offers revenue cycle management solutions such as athenaIDX for large practices, health systems, billing services, and hospitals.

Key Points: 
  • athenahealth Inc. - The company offers revenue cycle management solutions such as athenaIDX for large practices, health systems, billing services, and hospitals.
  • The US Revenue Cycle Management (RCM) market stands at the intersection of healthcare organizations' financial health and patient care quality.
  • The telecom billing revenue management market size is estimated to grow at a CAGR of 8.73% between 2022 and 2027.
  • Growth in infrastructure development is the key driver notably driving the growth of the global innovation management market.

R1 RCM to Present at Upcoming Investor Conferences

Retrieved on: 
Friday, February 16, 2024

MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences:

Key Points: 
  • MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences:
    The 2024 TD Cowen Healthcare Conference on Monday, March 4 at 10:30am ET
    The 2024 Barclays Global Healthcare Conference on Wednesday, March 13 at 4:35pm ET
    A live audio webcast of each presentation will be available on the Investor Relations section of R1’s website at r1rcm.com .
  • A replay of the webcast will be available for 90 days following the live webcast.

R1 Wins Multiple Best in KLAS Awards for Third Straight Year

Retrieved on: 
Wednesday, February 7, 2024

Now an 11-time Best in KLAS winner, R1 also earned top rankings this year for Government Reimbursement Services and Underpayment Recovery Services, the first and third time winning in these categories, respectively.

Key Points: 
  • Now an 11-time Best in KLAS winner, R1 also earned top rankings this year for Government Reimbursement Services and Underpayment Recovery Services, the first and third time winning in these categories, respectively.
  • “Healthcare providers need us now more than ever, and we are committed to meeting them where they are and helping them on their journey.
  • R1’s ability to integrate across multiple EHR's, maximize earned reimbursement for Medicare cost reports, and recover missed revenue opportunities make R1 a trusted partner in delivering comprehensive solutions that providers seek.
  • R1 clients surveyed by KLAS expressed their satisfaction with the company’s Ambulatory RCM Services, with one hospital CEO commenting in October 2023, “R1 is evolving in a challenging and changing healthcare business environment.